
EU approves Sanofi's next-gen rabies vaccine VaxRabeo for all ages, enhancing prevention and treatment options.
Sanofi's new rabies vaccine, VaxRabeo, has received European Commission approval for use in all age groups for both pre-exposure and post-exposure prophylaxis. The vaccine uses advanced Vero-cell technology, offering improved safety, longer shelf lif...


